Félix Balazard
@felbalazard
Followers
706
Following
24K
Statuses
14K
Adjusting trials @owkinscience PhD in statistics applied to epidemiology @felixbalazard.bsky.social
Joined November 2015
⚡️New preprint on the impact of covariate adjustment⚡️ 2 key messages: -Indications with a large proportion of events are more impacted by covariate adjustment -Covariate adjustment allows to broaden eligibility criteria 1/11
1
8
28
RT @AI4Pathology: For the past 5 years, our CLAM toolbox has been widely used by the community for whole-slide image (WSI) processing. For…
0
25
0
RT @BowTiedBiotech: 🐷🧬 Pig to Human kidney transplant Xenotransplantation of a Porcine Kidney for End-Stage Kidney Disease “ A 62-year-ol…
0
5
0
RT @kyutai_labs: Thanks to @Xavier75 for stopping by at the #AIActionSummit to try Hibiki. No need to struggle with English anymore 😅 https…
0
25
0
RT @itsolelehmann: Everyone says Europe can't compete with America in tech. But 48 hours ago, Mistral's 'Le Chat' just proved them wrong:…
0
4K
0
RT @honualx: We just released Hibiki, a 🎙️-to-🔊 simultaneous translation model 🇫🇷🇬🇧 We leverage a large synthetic corpus synthesized from…
0
7
0
RT @docmilanfar: .... yet the true value of technologies like LLMs is that we're getting the benefit of interacting with the collective kno…
0
14
0
RT @docmilanfar: Michael Jordan gave a short, excellent, and provocative talk recently in Paris - here's a few key ideas - It's all just m…
0
171
0
RT @gabriel_zucman: Cela semble absurde, et j’ai été choqué la première fois que je l’ai compris, mais la France – il n'y a pas d'autre mot…
0
2K
0
RT @Sports_bios: $BMY overall guidance is weak - the bright spot is Camzyos - 223MM in Q4 vs 156 MM in Q3 vs 139MM in Q2 ...
0
5
0
RT @OwkinScience: 🚀 @France24_fr broadcasts a segment on our Glioblastoma Moonshot Hackathon - interviewing hackathon attendees and our CEO…
0
3
0
RT @ehlJAMA: AI detected cancerous lesions which is not a heavy lift for the technology. What was reported here were secondary outcomes.…
0
3
0
RT @AI4Pathology: Great 🧵about 🧵THREADS, our new multimodal histology + genomic foundation model from @simocristea
0
8
0
RT @OwkinScience: We’re excited to share our latest work in collaboration with @bioptimus_ai, published as a pre-print on arXiv. Large fou…
0
4
0
RT @Yoshua_Bengio: The capabilities of general-purpose AI have increased rapidly in recent years and months. For example, we now see model…
0
11
0
RT @OwkinScience: We're excited to announce the first patient has been dosed in our Phase 1 clinical trial of OKN4395, a first-in-class EP2…
0
3
0
RT @AI4Pathology: ✨📣Introducing THREADS: a multimodal foundation model for pathology trained on paired histology and genomic data 🔬+🧬 We s…
0
61
0
RT @modella_ai: 🎉✨We are excited to report that PathChat™ DX, our clinical-grade, generative AI co-pilot for pathology, has officially rece…
0
59
0
RT @AI4Pathology: So exciting to see that PathChat published in @Nature last summer ( has now received FDA Breakthr…
0
32
0